| Literature DB >> 34448710 |
Michael P Schaub1, Marcela Tiburcio2, Nora Martínez-Vélez2, Atul Ambekar3, Roshan Bhad3, Andreas Wenger1, Christian Baumgartner1, Dzianis Padruchny4, Sergey Osipchik4, Vladimir Poznyak5, Dag Rekve5, Fabricio Landi Moraes6, André Luiz Monezi Andrade7, Maria Lucia Oliveira Souza-Formigoni6.
Abstract
BACKGROUND: Given the scarcity of alcohol prevention and use disorder treatments in many low- and middle-income countries (LMICs), the World Health Organization has launched an eHealth portal that includes the web-based self-help program "Alcohol e-Health."Entities:
Keywords: World Health Organization; alcohol; internet; public health; self-help
Mesh:
Year: 2021 PMID: 34448710 PMCID: PMC8433861 DOI: 10.2196/21686
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Alcohol use and use disorder indicators for the four low- and middle-income countries of interest in 2016, according to the World Health Organization global status report on alcohol and health 2018 [3].
| Country | Consumption of spirits as a proportion (%) of total alcoholic beverages recorded per capita in the last 12 monthsa | Heavy episodic drinking in the last 30 days (%)a | Alcohol use disorder prevalence (%)b | ||
|
|
| Male | Female | Male | Female |
| Belarus | 49.0 | 40.5 | 12.2 | 33.9 | 6.2 |
| Brazil | 34.0 | 32.6 | 6.9 | 6.9 | 1.6 |
| Mexico | 20.0 | 30.6 | 6.1 | 4.3 | 0.4 |
| India | 92.0 | 28.4 | 5.4 | 9.1 | 0.5 |
aAge 15+ years.
b12-month prevalence estimates including alcohol dependence and harmful use of alcohol (age 15+ years).
Overview of the study inclusion and exclusion criteria, and the rationale behind them.
| Criteria | Rationale | |
|
|
| |
|
| Age between 18 and 75 years | To ensure a minimal age of participation |
|
| A resident of one of the participating pilot countries | To be covered by local ethics board approval |
|
| At least weekly internet access | To ensure at least minimal program access |
|
| A screening AUDITa score ≥8 | To include adults with potentially hazardous or harmful alcohol consumption, and those whose drinking habits are suggestive of dependence |
|
|
| |
|
| Current substance abuse treatment | To avoid confounding treatment effects |
|
| Use of opioids, inhalants, cocaine/crack or amphetamine/amphetamine-like stimulants, sedatives over the past month, or cannabis/synthetic cannabinoids for more than 4 days over the past month | To prevent confounding effects with other frequently used mind-altering drugs |
aAUDIT: Alcohol Use Disorders Identification Test.
Overview of the study measurements.
| Assessments/instruments | Baselinea | Week 6 follow-up | Month 6 follow-upa |
| Sociodemographics | Yes | No | No |
| AUDITb score | Yes | No | Yes |
| Weekly number of standard drinksc | Yes | No | Yes |
| 8-item Client Satisfaction Questionnaire | No | Yes | No |
| Adverse effects | No | No | Yes |
aWhere “Yes” is indicated both at baseline and the 6-month follow-up, the outcome of interest is the change between baseline and the 6-month follow-up.
bAUDIT: Alcohol Use Disorders Identification Test.
cBased on a single question with seven answering fields asking about alcohol use, in standard drinks, on each day of a typical week.
Figure 1CONSORT-EHEALTH flowchart: overview of participant flow. CCA: complete case analysis; ITT: intention to treat.
Demographic and baseline characteristics of all centers and study arms.
| Characteristic | Brazil (N=587) | Mexico (N=509) | India (N=212) | Belarus (N=92) | Total | Statistical valuea | ||||||
|
| IGb (n=290) | CGc (n=297) | IG (n=256) | CG (n=253) | IG (n=95) | CG (n=117) | IG (n=46) | CG (n=46) |
|
|
| |
|
|
|
|
|
|
|
|
|
|
| χ2 (3)=68.9, N=1400 | <.001 | |
|
| Female | 99 (34.1%) | 125 (42.1%) | 57 (22.3%) | 82 (32.4%) | 10 (10.5%) | 9 (7.7%) | 16 (34.8%) | 20 (43.5%) | 418 (29.9%) |
|
|
|
| Male | 191 (65.9%) | 172 (57.9%) | 199 (77.7%) | 171 (67.6%) | 85 (89.5%) | 108 (92.3%) | 30 (65.2%) | 26 (56.5%) | 982 (70.1%) |
|
|
| Age (years), mean (SD) | 37.6 (10.6) | 36.6 (10.2) | 36.6 (11.0) | 36.4 (10.6) | 38.6 (9.5) | 40.3 (8.9) | 43.1 (9.4) | 41.0 (10.7) | 37.6 (10.5) | <.001 | ||
| Alcohol Use Disorders Identification Test (AUDIT) score, mean (SD) | 22.3 (6.8) | 22.2 (6.5) | 22.6 (6.3) | 22.3 (6.8) | 30.2 (7.2) | 30.2 (8.6) | 13.1 (4.1) | 14.4 (5.7) | 23.0 (7.7) | <.001 | ||
| Standard drinksd, mean (SD) | 44.6 (29.6) | 42.4 (28.6) | 28.3 (18.4) | 30.4 (19.6) | 93.0 (71.2) | 90.5 (69.1) | 14.5 (14.4) | 13.7 (12.4) | 43.7 (41.4) | <.001 | ||
| Drinking-free daysd, mean (SD) | 2.8 (2.0) | 2.2 (2.2) | 3.2 (2.0) | 2.4 (2.0) | 0.4 (1.3) | 0.2 (0.4) | 3.0 (1.3) | 2 (0.8) | 2.6 (2.0) | <.001 | ||
aChi-square test, analysis of variance, or Kruskal-Wallis test.
bIG: intervention group.
cCG: control group.
dLast 7 days.
Regression analysis results.
| Variable | Intervention versus control after 6 months (complete cases) (N=562) | ||
|
|
| 95% CI | |
| AUDITb | −4.18 | −5.42 to −2.93 | <.001 |
| Standard drinksc | −9.34 | −15.90 to −2.77 | .005 |
aBaseline data and condition as predictors for group effect.
bAUDIT: Alcohol Use Disorders Identification Test.
cLast 7 days.
Values between baseline and follow-up from complete cases.
| Variable | Control baseline (n=713), mean (SD) | Intervention baseline (n=687), mean (SD) | Control followed upa (n=325), mean (SD) | Intervention followed upa (n=239), mean (SD) |
| 95% CI |
| AUDITc | 23.05 (7.88) | 22.86 (7.50) | 18.71 (9.28) | 15.15 (9.06) | 0.56 | 0.38-0.72 |
| Standard drinksd | 44.21 (41.70) | 43.23 (41.13) | 23.73 (26.32) | 12.46 (16.31) | 0.28 | 0.08-0.46 |
| CSQ-8e | N/Af | N/A | 18.92 (4.65) | 21.56 (4.11) | 0.60 | 0.40-0.79 |
a6 months after baseline (complete cases).
bEffect size Cohen d based on differences between the intervention and control groups.
cAUDIT: Alcohol Use Disorders Identification Test.
dLast 7 days.
eCSQ-8: 8-item Client Satisfaction Questionnaire.
fN/A: not applicable.